A small biotech start-up based in Nelson aims to end to the suffering caused by viral disease and at the same time up-end the way pharmaceutical drugs are developed.
Kimer Med are developing a broad spectrum anti-viral medication which if successful will have the ability to treat a wide range of viral diseases - including HIV, Hepatitis and Covid-19
Recently the start-up was recognised with the 'Innovative Business' accolade at the Nelson Tasman Chamber of Commerce Business Awards.
Co-founder, chief science officer and CEO Rick Kiessig talks to Jesse about how it all works.
L to R: Dr Mike Schmidt – Business Development Manager; Andy Clover – Communications & Funding Specialist; Rick Kiessig – CEO & Chief Science Officer in Kimer Med’s new laboratory. Photo: www.kimermed.co.nz
